{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:47:47Z","timestamp":1767016067582,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of Hunan Provincial Health Commission","award":["No.B202319019225"],"award-info":[{"award-number":["No.B202319019225"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2022JJ30972, 2024JJ5584"],"award-info":[{"award-number":["2022JJ30972, 2024JJ5584"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Traditional Chinese Medicine Project in Jiangxi Province","award":["No.2023B0185, No.2022A281"],"award-info":[{"award-number":["No.2023B0185, No.2022A281"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14458-2","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T10:51:33Z","timestamp":1754995893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of sacubitril\/valsartan on chronic heart failure patients with sleep-disordered breathing: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Xuyuan","family":"Kuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siting","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"14458_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cardfail.2008.11.015","volume":"15","author":"D Yumino","year":"2009","unstructured":"Yumino, D. et al. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J. Card Fail. 15, 279\u2013285 (2009).","journal-title":"J. Card Fail."},{"key":"14458_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.109.901801","volume":"122","author":"DJ Gottlieb","year":"2010","unstructured":"Gottlieb, D. J. et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122, 352\u2013360 (2010).","journal-title":"Circulation"},{"key":"14458_CR3","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/eurheartj\/ehu522","volume":"36","author":"R Khayat","year":"2015","unstructured":"Khayat, R. et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur. Heart J. 36, 1463\u20131469 (2015).","journal-title":"Eur. Heart J."},{"key":"14458_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1164\/rccm.201511-2176ED","volume":"193","author":"MT Naughton","year":"2016","unstructured":"Naughton, M. T. Heart failure and Sleep-disordered breathing. The chicken or the egg?? Am. J. Respir Crit. Care Med. 193, 482\u2013483 (2016).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"14458_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cardfail.2014.10.017","volume":"21","author":"W Grimm","year":"2015","unstructured":"Grimm, W., Sosnovskaya, A., Timmesfeld, N., Hildebrandt, O. & Koehler, U. Prognostic impact of central sleep apnea in patients with heart failure. J. Card Fail. 21, 126\u2013133 (2015).","journal-title":"J. Card Fail."},{"key":"14458_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jacc.2014.10.025","volume":"65","author":"MR Costanzo","year":"2015","unstructured":"Costanzo, M. R. et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J. Am. Coll. Cardiol. 65, 72\u201384 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14458_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cardfail.2013.04.005","volume":"19","author":"R Khayat","year":"2013","unstructured":"Khayat, R. et al. Sleep-disordered breathing in heart failure: identifying and treating an important but often unrecognized comorbidity in heart failure patients. J. Card Fail. 19, 431\u2013444 (2013).","journal-title":"J. Card Fail."},{"key":"14458_CR8","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1161\/CIRCULATIONAHA.107.709303","volume":"115","author":"LJ Olson","year":"2007","unstructured":"Olson, L. J. & Somers, V. K. Treating central sleep apnea in heart failure: outcomes revisited. Circulation 115, 3140\u20133142 (2007).","journal-title":"Circulation"},{"key":"14458_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.chest.2015.12.021","volume":"149","author":"S Javaheri","year":"2016","unstructured":"Javaheri, S., Brown, L. K., Randerath, W. & Khayat, R. SERVE-HF: more questions than answers. Chest 149, 900\u2013904 (2016).","journal-title":"Chest"},{"key":"14458_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/17425247.2021.1860940","volume":"18","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Du, X., Wang, H., He, Z. & Liu, H. Sacubitril-valsartan cocrystal revisited: role of polymer excipients in the formulation. Expert Opin. Drug Deliv. 18, 515\u2013526 (2021).","journal-title":"Expert Opin. Drug Deliv"},{"key":"14458_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ehf2.12270","volume":"5","author":"D Jaffuel","year":"2018","unstructured":"Jaffuel, D. et al. Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep Apnoea syndrome: the ENTRESTO-SAS study design. ESC Heart Fail. 5, 222\u2013230 (2018).","journal-title":"ESC Heart Fail."},{"key":"14458_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray, J. J. et al. Angiotensin-neprilysin Inhibition versus Enalapril in heart failure. N Engl. J. Med. 371, 993\u20131004 (2014).","journal-title":"N Engl. J. Med."},{"key":"14458_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrcardio.2016.71","volume":"13","author":"G Parati","year":"2016","unstructured":"Parati, G. et al. Heart failure and sleep disorders. Nat. Rev. Cardiol. 13, 389\u2013403 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"14458_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.healun.2018.07.005","volume":"37","author":"A Apostolo","year":"2018","unstructured":"Apostolo, A. et al. Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance. J. Heart Lung Transpl. 37, 1361\u20131371 (2018).","journal-title":"J. Heart Lung Transpl."},{"key":"14458_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000455118","volume":"137","author":"H Fox","year":"2017","unstructured":"Fox, H., Bitter, T., Horstkotte, D. & Oldenburg, O. Resolution of Cheyne-Stokes respiration after treatment of heart failure with sacubitril\/valsartan: A first case report. Cardiology 137, 96\u201399 (2017).","journal-title":"Cardiology"},{"key":"14458_CR16","first-page":"125","volume":"36","author":"LW Liu","year":"2020","unstructured":"Liu, L. W., Wu, P. C., Chiu, M. Y., Tu, P. F. & Fang, C. C. Sacubitril\/Valsartan improves left ventricular ejection fraction and reverses cardiac remodeling in Taiwanese patients with heart failure and reduced ejection fraction. Acta Cardiol. Sin. 36, 125\u2013132 (2020).","journal-title":"Acta Cardiol. Sin"},{"key":"14458_CR17","doi-asserted-by":"publisher","first-page":"861663","DOI":"10.3389\/fcvm.2022.861663","volume":"9","author":"C Pelaia","year":"2022","unstructured":"Pelaia, C. et al. Effects of Sacubitril-Valsartan on clinical, echocardiographic, and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea. Front. Cardiovasc. Med. 9, 861663 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"14458_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1006\/enrs.1993.1078","volume":"61","author":"T Sato","year":"1993","unstructured":"Sato, T., Kawada, T., Ogawa, M., Aoki, S. & Suzuki, S. Effect of some factors on sleep polygraphic parameters and subjective evaluations of sleep. Environ. Res. 61, 337\u2013348 (1993).","journal-title":"Environ. Res."},{"key":"14458_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/1871527320666211022104140","volume":"21","author":"L Buratti","year":"2022","unstructured":"Buratti, L. et al. Sex-Related differences in polygraphic parameters in a population of patients with obstructive sleep apnea syndrome. CNS Neurol. Disord Drug Targets. 21, 492\u2013499 (2022).","journal-title":"CNS Neurol. Disord Drug Targets"},{"key":"14458_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst. Rev. 10, 89 (2021).","journal-title":"Syst. Rev."},{"key":"14458_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.prosdent.2016.01.028","volume":"116","author":"P Tsirogiannis","year":"2016","unstructured":"Tsirogiannis, P., Reissmann, D. R. & Heydecke, G. Evaluation of the marginal fit of single-unit, complete-coverage ceramic restorations fabricated after digital and conventional impressions: A systematic review and meta-analysis. J. Prosthet. Dent. 116, 328\u2013335e322 (2016).","journal-title":"J. Prosthet. Dent."},{"key":"14458_CR22","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj 366, l4898 (2019).","journal-title":"Bmj"},{"key":"14458_CR23","doi-asserted-by":"publisher","first-page":"111492","DOI":"10.1016\/j.jclinepi.2024.111492","volume":"174","author":"JE McKenzie","year":"2024","unstructured":"McKenzie, J. E. & Veroniki, A. A. A brief note on the random-effects meta-analysis model and its relationship to other models. J. Clin. Epidemiol. 174, 111492 (2024).","journal-title":"J. Clin. Epidemiol."},{"key":"14458_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088\u20131101 (1994).","journal-title":"Biometrics"},{"key":"14458_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. Bmj 315, 629\u2013634 (1997).","journal-title":"Bmj"},{"key":"14458_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11325-022-02623-0","volume":"27","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Branco, R. F., Salanitro, M., Penzel, T. & Sch\u00f6bel, C. Effects of sacubitril-valsartan on central and obstructive Apneas in heart failure patients with reduced ejection fraction. Sleep. Breath. 27, 283\u2013289 (2023).","journal-title":"Sleep. Breath."},{"key":"14458_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40256-020-00440-y","volume":"21","author":"RM Khandwalla","year":"2021","unstructured":"Khandwalla, R. M. et al. The AWAKE-HF study: sacubitril\/valsartan impact on daily physical activity and sleep in heart failure. Am. J. Cardiovasc. Drugs. 21, 241\u2013254 (2021).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"14458_CR28","doi-asserted-by":"publisher","first-page":"971108","DOI":"10.3389\/fcvm.2022.971108","volume":"9","author":"M Mapelli","year":"2022","unstructured":"Mapelli, M. et al. Impact of sacubitril\/valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: hemodynamic or pleiotropism? Front. Cardiovasc. Med. 9, 971108 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"14458_CR29","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/ehf2.13455","volume":"8","author":"D Jaffuel","year":"2021","unstructured":"Jaffuel, D. et al. Sacubitril-valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO-SAS study. ESC Heart Fail. 8, 2513\u20132526 (2021).","journal-title":"ESC Heart Fail."},{"key":"14458_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijcard.2021.02.012","volume":"330","author":"C Passino","year":"2021","unstructured":"Passino, C. et al. Sacubitril-valsartan treatment is associated with decrease in central Apneas in patients with heart failure with reduced ejection fraction. Int. J. Cardiol. 330, 112\u2013119 (2021).","journal-title":"Int. J. Cardiol."},{"key":"14458_CR31","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.cardfail.2021.07.021","volume":"27","author":"RL Owens","year":"2021","unstructured":"Owens, R. L. et al. Sleep outcomes from AWAKE-HF: A randomized clinical trial of sacubitril\/valsartan vs Enalapril in patients with heart failure and reduced ejection fraction. J. Card Fail. 27, 1466\u20131471 (2021).","journal-title":"J. Card Fail."},{"key":"14458_CR32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.5664\/jcsm.11040","volume":"20","author":"RK Malhotra","year":"2024","unstructured":"Malhotra, R. K. AASM scoring manual 3: a step forward for advancing sleep care for patients with obstructive sleep apnea. J. Clin. Sleep. Med. 20, 835\u2013836 (2024).","journal-title":"J. Clin. Sleep. Med."},{"key":"14458_CR33","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.jchf.2024.03.014","volume":"12","author":"S Chatur","year":"2024","unstructured":"Chatur, S. et al. Sacubitril\/Valsartan in patients with heart failure and deterioration in eGFR to <\u200930 mL\/min\/1.73 m(2). JACC Heart Fail. 12, 1692\u20131703 (2024).","journal-title":"JACC Heart Fail."},{"key":"14458_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ejhf.1342","volume":"21","author":"H Nougu\u00e9","year":"2019","unstructured":"Nougu\u00e9, H. et al. Effects of sacubitril\/valsartan on Neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study. Eur. J. Heart Fail. 21, 598\u2013605 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"14458_CR35","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jchf.2024.07.010","volume":"12","author":"JL Jefferies","year":"2024","unstructured":"Jefferies, J. L. Sacubitril\/Valsartan in heart failure and deterioration in eGFR: slow and steady win the race. JACC Heart Fail. 12, 1704\u20131706 (2024).","journal-title":"JACC Heart Fail."},{"key":"14458_CR36","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1161\/CIRCULATIONAHA.119.039920","volume":"140","author":"S Selvaraj","year":"2019","unstructured":"Selvaraj, S. et al. Prognostic implications of congestion on physical examination among contemporary patients with heart failure and reduced ejection fraction: PARADIGM-HF. Circulation 140, 1369\u20131379 (2019).","journal-title":"Circulation"},{"key":"14458_CR37","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","volume":"73","author":"PL Myhre","year":"2019","unstructured":"Myhre, P. L. et al. B-Type natriuretic peptide during treatment with sacubitril\/valsartan: the PARADIGM-HF trial. J. Am. Coll. Cardiol. 73, 1264\u20131272 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14458_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1569-9048(02)00114-3","volume":"132","author":"S Gunawardena","year":"2002","unstructured":"Gunawardena, S. et al. Responses of C fiber afferents of the rabbit airways and lungs to changes in extra-vascular fluid volume. Respir Physiol. Neurobiol. 132, 239\u2013251 (2002).","journal-title":"Respir Physiol. Neurobiol."},{"key":"14458_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1113\/expphysiol.2014.082826","volume":"100","author":"MP Mansukhani","year":"2015","unstructured":"Mansukhani, M. P., Wang, S. & Somers, V. K. Chemoreflex physiology and implications for sleep apnoea: insights from studies in humans. Exp. Physiol. 100, 130\u2013135 (2015).","journal-title":"Exp. Physiol."},{"key":"14458_CR40","unstructured":"Sasc\u0103u, R. et al. Review of Echocardiographic Findings in Patients with Obstructive Sleep Apnea. Can Respir J. 1206217 (2018). (2018)."},{"key":"14458_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ejhf.1402","volume":"21","author":"O Vardeny","year":"2019","unstructured":"Vardeny, O. et al. Reduced loop diuretic use in patients taking sacubitril\/valsartan compared with enalapril: the PARADIGM-HF trial. Eur. J. Heart Fail. 21, 337\u2013341 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"14458_CR42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11325-018-1764-x","volume":"23","author":"J Spiesshoefer","year":"2019","unstructured":"Spiesshoefer, J. et al. Reduction of sleep-disordered breathing following effective percutaneous mitral valve repair with the MitraClip system. Sleep. Breath. 23, 815\u2013824 (2019).","journal-title":"Sleep. Breath."},{"key":"14458_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fcvm.2019.00125","volume":"6","author":"C Borrelli","year":"2019","unstructured":"Borrelli, C. et al. Central and obstructive Apneas in heart failure with reduced, Mid-Range and preserved ejection fraction. Front. Cardiovasc. Med. 6, 125 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"14458_CR44","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1378\/chest.07-0121","volume":"132","author":"T Brack","year":"2007","unstructured":"Brack, T. et al. Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest 132, 1463\u20131471 (2007).","journal-title":"Chest"},{"key":"14458_CR45","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.jacc.2017.07.740","volume":"70","author":"M Emdin","year":"2017","unstructured":"Emdin, M. et al. Prognostic significance of central Apneas throughout a 24-Hour period in patients with heart failure. J. Am. Coll. Cardiol. 70, 1351\u20131364 (2017).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14458-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14458-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14458-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:06:44Z","timestamp":1757380004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14458-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14458"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14458-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29524"}}